PI
Putnam Investments Portfolio holdings
AUM
$75.7B
1-Year Return
34.47%
This Quarter Return
-2.34%
1 Year Return
+34.47%
3 Year Return
+62.08%
5 Year Return
+203.67%
10 Year Return
+403.53%
AUM
$52.6B
AUM Growth
-$3.21B
(-5.8%)
Cap. Flow
-$1.14B
Cap. Flow
% of AUM
-2.17%
Top 10 Holdings %
Top 10 Hldgs %
24.55%
Holding
1,245
New
126
Increased
333
Reduced
642
Closed
106
Top Buys
| 1 |
Ingersoll Rand
IR
|
+$263M |
| 2 |
Humana
HUM
|
+$223M |
| 3 |
Eli Lilly
LLY
|
+$146M |
| 4 |
Abbott
ABT
|
+$99.8M |
| 5 |
Gartner
IT
|
+$97.7M |
Top Sells
| 1 |
Johnson & Johnson
JNJ
|
+$500M |
| 2 |
Eaton
ETN
|
+$254M |
| 3 |
Northrop Grumman
NOC
|
+$218M |
| 4 |
Fidelity National Information Services
FIS
|
+$171M |
| 5 |
Aramark
ARMK
|
+$160M |
Sector Composition
| 1 | Technology | 20.38% |
| 2 | Healthcare | 18.47% |
| 3 | Financials | 12.77% |
| 4 | Consumer Discretionary | 10.16% |
| 5 | Industrials | 9.03% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
826
Gilead Sciences
GILD
$142B
| $531K | ﹤0.01% |
8,609
-157
| -2% | -$9.68K |
|
827
FS KKR Capital
FSK
$4.99B
| $530K | ﹤0.01% |
+31,249
| New | +$530K |
|
828
Ares Capital
ARCC
$15.7B
| $528K | ﹤0.01% |
+31,315
| New | +$528K |
|
829
CTS Corp
CTS
$1.22B
| $528K | ﹤0.01% |
12,683
-227
| -2% | -$9.45K |
|
830
RAPT Therapeutics
RAPT
$229M
| $525K | ﹤0.01% |
2,728
+237
| +10% | +$45.6K |
|
831
New Jersey Resources
NJR
$4.69B
| $523K | ﹤0.01% |
13,533
-248
| -2% | -$9.58K |
|
|
AEL
832
DELISTED
American Equity Investment Life Holding Company
AEL
| $521K | ﹤0.01% |
13,974
-255
| -2% | -$9.51K |
|
833
BioCryst Pharmaceuticals
BCRX
$1.68B
| $518K | ﹤0.01% |
41,155
-748
| -2% | -$9.42K |
|
834
IBM
IBM
$238B
| $516K | ﹤0.01% |
4,340
+668
| +18% | +$79.4K |
|
835
Standex International
SXI
$2.43B
| $516K | ﹤0.01% |
6,319
-113
| -2% | -$9.23K |
|
836
Eagle Bancorp
EGBN
$592M
| $507K | ﹤0.01% |
11,324
-202
| -2% | -$9.04K |
|
837
Titan International
TWI
$542M
| $503K | ﹤0.01% |
41,421
-745
| -2% | -$9.05K |
|
838
Crocs
CROX
$4.4B
| $495K | ﹤0.01% |
7,210
+324
| +5% | +$22.2K |
|
839
ESCO Technologies
ESE
$5.26B
| $484K | ﹤0.01% |
6,592
-116
| -2% | -$8.52K |
|
840
Select Medical
SEM
$1.53B
| $484K | ﹤0.01% |
40,617
-87,352
| -68% | -$1.04M |
|
|
NGM
841
DELISTED
NGM Biopharmaceuticals, Inc. Common Stock
NGM
| $483K | ﹤0.01% |
36,900
-666
| -2% | -$8.72K |
|
842
NETSCOUT
NTCT
$1.8B
| $474K | ﹤0.01% |
15,142
-273
| -2% | -$8.55K |
|
843
Selective Insurance
SIGI
$4.72B
| $472K | ﹤0.01% |
5,801
-103
| -2% | -$8.38K |
|
844
SunCoke Energy
SXC
$649M
| $471K | ﹤0.01% |
81,153
-1,474
| -2% | -$8.56K |
|
|
TCDA
845
DELISTED
Tricida, Inc. Common Stock
TCDA
| $467K | ﹤0.01% |
+44,551
| New | +$467K |
|
846
National Health Investors
NHI
$3.7B
| $466K | ﹤0.01% |
8,237
-148
| -2% | -$8.37K |
|
|
NVEE
847
DELISTED
NV5 Global
NVEE
| $465K | ﹤0.01% |
15,016
+2,124
| +16% | +$65.8K |
|
|
DOOR
848
DELISTED
MASONITE INTERNATIONAL CORP
DOOR
| $465K | ﹤0.01% |
6,513
-116
| -2% | -$8.28K |
|
|
IGMS
849
DELISTED
IGM Biosciences
IGMS
| $460K | ﹤0.01% |
20,235
-356
| -2% | -$8.09K |
|
850
Crinetics Pharmaceuticals
CRNX
$3.33B
| $458K | ﹤0.01% |
23,351
-423
| -2% | -$8.3K |
|